These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 30304549
1. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells. Zhang S, Chang YY, Gong YW, Gao YJ, Guo Q, Wang YH, Zhao YL, Wang ZP. J Cell Biochem; 2019 Apr; 120(4):6347-6360. PubMed ID: 30304549 [Abstract] [Full Text] [Related]
2. Mechanism Comparison of Gemcitabine and Dasatinib-Resistant Pancreatic Cancer by Integrating mRNA and miRNA Expression Profiles. Chen Z, Zhao L, Shi K, Chen B. Clin Lab; 2018 May 01; 64(5):749-757. PubMed ID: 29739052 [Abstract] [Full Text] [Related]
3. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells. Shen Y, Pan Y, Xu L, Chen L, Liu L, Chen H, Chen Z, Meng Z. Tumour Biol; 2015 Jun 01; 36(6):4525-34. PubMed ID: 25722110 [Abstract] [Full Text] [Related]
4. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC. Lou W, Liu J, Ding B, Chen D, Xu L, Ding J, Jiang D, Zhou L, Zheng S, Fan W. J Transl Med; 2019 Jan 03; 17(1):7. PubMed ID: 30602391 [Abstract] [Full Text] [Related]
5. BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell. Chen MK, Zhou JH, Wang P, Ye YL, Liu Y, Zhou JW, Chen ZJ, Yang JK, Liao DY, Liang ZJ, Xie X, Zhou QZ, Xue KY, Guo WB, Xia M, Bao JM, Yang C, Duan HF, Wang HY, Huang ZP, Qin ZK, Liu CD. Aging (Albany NY); 2021 Jul 16; 13(14):18310-18330. PubMed ID: 34270461 [Abstract] [Full Text] [Related]
6. Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics Analysis. Li C, Hong Z, Ou M, Zhu X, Zhang L, Yang X. Biomed Res Int; 2021 Jul 16; 2021():6673655. PubMed ID: 34734085 [Abstract] [Full Text] [Related]
7. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays. Shen H, Wang W, Ni B, Zou Q, Lu H, Wang Z. Int J Mol Med; 2018 Jul 16; 42(1):21-30. PubMed ID: 29620143 [Abstract] [Full Text] [Related]
8. Analysis of Gene Expression in Bladder Cancer: Possible Involvement of Mitosis and Complement and Coagulation Cascades Signaling Pathway. Liu Y, Xiong S, Liu S, Chen J, Yang H, Liu G, Li G. J Comput Biol; 2020 Jun 16; 27(6):987-998. PubMed ID: 31545079 [Abstract] [Full Text] [Related]
9. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W, Chen J, Ding B, Chen D, Zheng H, Jiang D, Xu L, Bao C, Cao G, Fan W. J Transl Med; 2018 Sep 29; 16(1):266. PubMed ID: 30268144 [Abstract] [Full Text] [Related]
10. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression. Yang Y, Zhang G, Li J, Gong R, Wang Y, Qin Y, Ping Q, Hu L. Pathol Res Pract; 2021 Dec 29; 228():153676. PubMed ID: 34753061 [Abstract] [Full Text] [Related]
11. Bioinformatic analysis of microRNA-mRNA expression profiles of bladder tissue induced by bladder outlet obstruction in a rat model. Duan LJ, Cao QF, Xu D, Liu HL, Qi J. Mol Med Rep; 2017 Oct 29; 16(4):4803-4810. PubMed ID: 28791388 [Abstract] [Full Text] [Related]
12. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis. Jin N, Jin X, Gu X, Na W, Zhang M, Zhao R. Mol Med Rep; 2015 Aug 29; 12(2):3170-6. PubMed ID: 25955758 [Abstract] [Full Text] [Related]
13. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer. Xue B, Li S, Jin X, Liu L. BMC Cancer; 2021 Apr 23; 21(1):452. PubMed ID: 33892654 [Abstract] [Full Text] [Related]
14. Integrated miRNA-mRNA network revealing the key molecular characteristics of ossification of the posterior longitudinal ligament. Xu G, Liu C, Liang T, Qin Z, Yu CJ, Zhang Z, Jiang J, Chen J, Zhan X. Medicine (Baltimore); 2020 May 22; 99(21):e20268. PubMed ID: 32481304 [Abstract] [Full Text] [Related]
15. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis. Zhong X, Huang G, Ma Q, Liao H, Liu C, Pu W, Xu L, Cai Y, Guo X. Medicine (Baltimore); 2019 Jul 22; 98(27):e16269. PubMed ID: 31277149 [Abstract] [Full Text] [Related]
16. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis. Peng C, Yang Q, Wei B, Yuan B, Liu Y, Li Y, Gu D, Yin G, Wang B, Xu D, Zhang X, Kong D. Mol Med Rep; 2017 Nov 22; 16(5):7617-7624. PubMed ID: 28944822 [Abstract] [Full Text] [Related]
17. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Pan J, Li X, Wu W, Xue M, Hou H, Zhai W, Chen W. Cancer Lett; 2016 Nov 01; 382(1):64-76. PubMed ID: 27591936 [Abstract] [Full Text] [Related]
18. miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a. Cao J, Wang Q, Wu G, Li S, Wang Q. Int Urol Nephrol; 2018 Oct 01; 50(10):1811-1819. PubMed ID: 30117016 [Abstract] [Full Text] [Related]
19. Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells. Zhang X, Taoka R, Liu D, Matsuoka Y, Tohi Y, Kakehi Y, Sugimoto M. Int J Mol Sci; 2021 Apr 15; 22(8):. PubMed ID: 33921102 [Abstract] [Full Text] [Related]
20. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines. Zhang HH, Zhang ZY, Che CL, Mei YF, Shi YZ. Int J Clin Exp Pathol; 2013 Apr 15; 6(9):1734-46. PubMed ID: 24040438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]